Lonsurf Evrópusambandið - íslenska - EMA (European Medicines Agency)

lonsurf

les laboratoires servier - trifluridine, tipiracil stutt og long-term - litlaræxli - Æxlishemjandi lyf - colorectal cancerlonsurf is indicated in combination with bevacizumab for the treatment of adult patients with metastatic colorectal cancer (crc) who have received two prior anticancer treatment regimens including fluoropyrimidine-, oxaliplatin- and irinotecan-based chemotherapies, anti-vegf agents, and/or anti-egfr agents. lonsurf is indicated as monotherapy for the treatment of adult patients with metastatic colorectal cancer (crc) who have been previously treated with, or are not considered candidates for, available therapies including fluoropyrimidine-, oxaliplatin- and irinotecan-based chemotherapies, anti-vegf agents, and anti egfr agentsgastric cancerlonsurf is indicated as monotherapy for the treatment of adult patients with metastatic gastric cancer including adenocarcinoma of the gastroesophageal junction, who have been previously treated with at least two prior systemic treatment regimens for advanced disease.

Inaqovi Evrópusambandið - íslenska - EMA (European Medicines Agency)

inaqovi

otsuka pharmaceutical netherlands b.v. - cedazuridine, decitabine - kyrningahvítblæði, mergbólga - Æxlishemjandi lyf - inaqovi is indicated as monotherapy for the treatment of adult patients with newly diagnosed acute myeloid leukaemia (aml) who are ineligible for standard induction chemotherapy.

Segluromet Evrópusambandið - íslenska - EMA (European Medicines Agency)

segluromet

merck sharp & dohme b.v. - ertugliflozin l-pyroglutamic acid, metformin hydrochloride - sykursýki, tegund 2 - drugs used in diabetes, combinations of oral blood glucose lowering drugs - segluromet is indicated in adults aged 18 years and older with type 2 diabetes mellitus as an adjunct to diet and exercise to improve glycaemic control:in patients not adequately controlled on their maximally tolerated dose of metformin alonein patients on their maximally tolerated doses of metformin in addition to other medicinal products for the treatment of diabetesin patients already being treated with the combination of ertugliflozin and metformin as separate tablets.

Flúoróúracil Accord Stungulyf/innrennslislyf, lausn 50 mg/ml Ísland - íslenska - LYFJASTOFNUN (Icelandic Medicines Agency)

flúoróúracil accord stungulyf/innrennslislyf, lausn 50 mg/ml

accord healthcare b.v. - fluorouracilum inn - stungulyf/innrennslislyf, lausn - 50 mg/ml

Irinotecan Accord Innrennslisþykkni, lausn 20 mg/ml Ísland - íslenska - LYFJASTOFNUN (Icelandic Medicines Agency)

irinotecan accord innrennslisþykkni, lausn 20 mg/ml

accord healthcare b.v. - irinotecanum hýdróklóríð - innrennslisþykkni, lausn - 20 mg/ml

Onivyde pegylated liposomal (previously known as Onivyde) Evrópusambandið - íslenska - EMA (European Medicines Agency)

onivyde pegylated liposomal (previously known as onivyde)

les laboratoires servier - irinotecan anhydrous free-base - brisbólga - Æxlishemjandi lyf - meðferð af sjúklingum krabbamein í brisi í bland með 5 fluorouracil (5 fu) og leukovorin (vuitton), í fullorðinn sjúklingar sem hafa gengið eftir gemcitabin byggt meðferð.

Doxorubicin medac Innrennslislyf, lausn 2 mg/ml Ísland - íslenska - LYFJASTOFNUN (Icelandic Medicines Agency)

doxorubicin medac innrennslislyf, lausn 2 mg/ml

medac gesellschaft für klinische spezialpräparate gmbh - doxorubicinum hýdróklóríð - innrennslislyf, lausn - 2 mg/ml

Flagyl Filmuhúðuð tafla 400 mg Ísland - íslenska - LYFJASTOFNUN (Icelandic Medicines Agency)

flagyl filmuhúðuð tafla 400 mg

sanofi-aventis norge as - metronidazolum inn - filmuhúðuð tafla - 400 mg

Flagyl Leggangastíll 500 mg Ísland - íslenska - LYFJASTOFNUN (Icelandic Medicines Agency)

flagyl leggangastíll 500 mg

sanofi-aventis norge as - metronidazolum inn - leggangastíll - 500 mg